PharmaTimesNews & Politicsnews

R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia

Wednesday, July 22, 2026John PinchingView original

First patient randomised as study advances novel pan phosphate transporter inhibitor

Read the full article on the original site.